Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil

OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.

Saved in:
Bibliographic Details
Main Authors: Carrilho,Flair Jose, Kikuchi,Luciana, Branco,Fernanda, Goncalves,Carlos Sandoval, Mattos,Angelo Aves de
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322010001200010
record_format ojs
spelling oai:scielo:S1807-593220100012000102011-03-21Clinical and epidemiological aspects of hepatocellular carcinoma in BrazilCarrilho,Flair JoseKikuchi,LucianaBranco,FernandaGoncalves,Carlos SandovalMattos,Angelo Aves de Hepatocellular carcinoma Epidemiology Liver cancer Brazil Treatment OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.65 n.12 20102010-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010en10.1590/S1807-59322010001200010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Carrilho,Flair Jose
Kikuchi,Luciana
Branco,Fernanda
Goncalves,Carlos Sandoval
Mattos,Angelo Aves de
spellingShingle Carrilho,Flair Jose
Kikuchi,Luciana
Branco,Fernanda
Goncalves,Carlos Sandoval
Mattos,Angelo Aves de
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
author_facet Carrilho,Flair Jose
Kikuchi,Luciana
Branco,Fernanda
Goncalves,Carlos Sandoval
Mattos,Angelo Aves de
author_sort Carrilho,Flair Jose
title Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
title_short Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
title_full Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
title_fullStr Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
title_full_unstemmed Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
title_sort clinical and epidemiological aspects of hepatocellular carcinoma in brazil
description OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.
publisher Faculdade de Medicina / USP
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010
work_keys_str_mv AT carrilhoflairjose clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil
AT kikuchiluciana clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil
AT brancofernanda clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil
AT goncalvescarlossandoval clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil
AT mattosangeloavesde clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil
_version_ 1756432091626602496